all of which are extremely expensive, said Dr. David Koczerginski, an entrepreneur of Psychiatry and Medical Director, Mental Health and Addiction, William Osler Health System and principal investigator of the study. Our data clearly show that the use of a treatment of long-acting injection given by a health professional every two weeks, can lead to significant clinical benefits for the benefit of patients and financial support for the health system. Velligan et al. Psychiatric Services [1075-2730 1075-2730] Velligan 2007 vol.58 iss.9 pg.1187 -1192.
A new study published in the quarterly Health has found that patients from oral medications to long-acting injection treatment had significantly fewer hospitalizations and visits to emergency services, saving the health system more than $ 17,300 a year and patient. 
Oral medications, the current first-line treatment for patients, should be taken daily. Up to 60 % of patients with schizophrenia do not take their medications as prescribed  a major challenge of current treatment of schizophrenia, such as non-adherence to therapy is associated with an increase relapse.1
. In short, is to focus on what our patients can do and that allows them to work within these parameters.
 Goeree, R., F. Farahat, N. Burke, G. Blackhouse, D. O’Reilly, J. Pyne et al. The economic burden of schizophrenia in Canada in 2004. The current medical research and opinion 21: 2017-28.
The cost savings and improved clinical outcomes in our study for patients treated with long-acting injectable suggest that hospitals should consider expanding the clinical long-acting injection, as a way to save resources and reduce costs and keep patients well, he said. Koczerginski.
Relapse in schizophrenia may cause personal distress and interfere with rehabilitation activities.
 Moreover, relapses often involve the use of resources and clinics, as the attention of emergency services, prolonged hospitalization and residential care.1